neuroscience innovation

Dateline – November 17 2025 | Tokyo, Japan & Cambridge/London, UK Nxera Pharma announced a major restructuring initiative aimed...

CORAL GABLES, Fla., November 4, 2025 — Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage biopharmaceutical company focused on developing...

AURORA, Colo., Sept. 30, 2025 — Researchers at the University of Colorado Anschutz Medical Campus announced the first FDA-authorized...